Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Immunology | Musculoskeletal | Rheumatology | Family Medicine
Search Medical Condition
Lupus Clinical Trials
A listing of Lupus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (219) clinical trials
Do you suffer from SLE Lupus?
A clinical research study of an investigational medication for SLE Lupus patients is being held in Tampa.
A Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects With Active Systemic Lupus Erythematosus (SLE)
This is a randomized, placebo controlled, double blind study. Following a screening period of up to 28 days, subjects with active systemic lupus erythematosus (SLE) including moderate to severe rash and/or arthritis despite corticosteroid therapy will be randomized in a 1:1 ratio to receive 1 mL (80 Units [U]) of ...
A Double-blind, Randomized, Placebo-controlled Trial Evaluating the Effect of BI 655064 Administered as Sub-cutaneous Injections, on Renal Response After One Year of Treatment, in Patients With Active Lupus Nephritis
The overall purpose of the study is to assess the efficacy of three different doses of BI 655064 against placebo as add-on therapy to standard of care (SOC) treatment for active lupus nephritis in order to characterize the dose-response relationship within the therapeutic range, and select the target dose for ...
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
The purpose of this clinical trial is to determine whether an investigational treatment, when added to either rituximab or cyclophosphamide, can improve your vasculitis disease activity, kidney function, and/or quality of life.
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...
Rash or lesions on the skin due to lupus (CLE)
A research study is evaluating an investigational medication for cutaneous lupus erythematosus (CLE). This research study may be an option if you: Are 18 to 75 years of age Have been diagnosed with CLE with or without a diagnosis of systemic lupus erythematosus (SLE) Have at least one active discoid ...
Cutaneous Lupus Erythematosus
People with Cutaneous Lupus Erythematosus are asked to participate in a research study being conducted by Northwell Health, North Shore University Hospital.
A research study in subjects with Systemic Lupus Erythematosus to evaluate the clinical activity of an investigational medication.
This is approximately a 30 week study. Compensation may be provided for time and travel.
Lupus Nephritis
The drug being tested is called belimumab. It is a prescription medicine to treate active systemic lupus erythematosus who are receiving other lupus medicines. The purpose of the study is to find out if belimumab is effective and safe in treating patients with active lupus nephritis who are receiving other ...
